(Q57570360)

English

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

article by Lorenzo Pilla et al published 8 October 2005 in Cancer Immunology, Immunotherapy

In more languages

edit

Statements

instance of

scholarly article

0 references

title

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients (English)

0 references

main subject

phase II clinical trial

1 reference

1 reference

Roberto Patuzzo

2

0 references

Andrea Maurichi

object named as

Andrea Maurichi

series ordinal

7

0 references

Samuele Massarut

object named as

Samuele Massarut

series ordinal

8

0 references

Alfonso Marchianò

object named as

Alfonso Marchianò

series ordinal

9

0 references

Mario Santinami

object named as

Mario Santinami

series ordinal

22

0 references

Michele Maio

object named as

Michele Maio

series ordinal

4

0 references

Licia Rivoltini

object named as

Licia Rivoltini

series ordinal

3

0 references

Elda Lamaj

0 references

author name string

Lorenzo Pilla

series ordinal

1

0 references

Elisabetta Pennacchioli

series ordinal

5

0 references

Elda Lamaj

series ordinal

6

0 references

Cristina Santantonio

series ordinal

10

0 references

Diego Tosi

series ordinal

11

0 references

Flavio Arienti

series ordinal

12

0 references

Agata Cova

series ordinal

13

0 references

Gloria Sovena

series ordinal

14

0 references

Adriano Piris

series ordinal

15

0 references

Daisuke Nonaka

series ordinal

16

0 references

Ilaria Bersani

series ordinal

17

0 references

Annabella Di Florio

series ordinal

18

0 references

Mariani Luigi

series ordinal

19

0 references

Pramod K. Srivastava

series ordinal

20

0 references

Axel Hoos

series ordinal

21

0 references

Giorgio Parmiani

series ordinal

23

0 references

publication date

8 October 2005

0 references

published in

Cancer Immunology, Immunotherapy

0 references

volume

55

0 references

issue

8

0 references

page(s)

958-968

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00262-005-0084-8

0 references

cites work

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00262-005-0084-8

retrieved

21 January 2018

The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00262-005-0084-8

retrieved

21 January 2018

Identifiers

DOI

10.1007/S00262-005-0084-8

0 references

PubMed publication ID

16215718

0 references

(Q57570360)

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)